PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT03618030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: PRC-063 oral capsules
DRUG: Placebo oral capsules

Sponsor

Purdue Pharma, Canada